Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7.

Chhablani J, Rani PK, Balakrishnan D, Jalali S.

Semin Ophthalmol. 2014 Jul;29(4):222-5. doi: 10.3109/08820538.2013.835842. Epub 2013 Oct 11.

PMID:
24117452
[PubMed - indexed for MEDLINE]
2.

Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5.

Jalali S, Balakrishnan D, Zeynalova Z, Padhi TR, Rani PK.

Arch Dis Child Fetal Neonatal Ed. 2013 Jul;98(4):F327-33. doi: 10.1136/archdischild-2012-302365. Epub 2012 Dec 25.

PMID:
23269586
[PubMed - indexed for MEDLINE]
3.

Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.

Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group.

JAMA Ophthalmol. 2014 Nov;132(11):1327-33. doi: 10.1001/jamaophthalmol.2014.2772.

PMID:
25103848
[PubMed - indexed for MEDLINE]
4.

[Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].

Autrata R, Senková K, Holousová M, Krejcírová I, Dolezel Z, Borek I.

Cesk Slov Oftalmol. 2012 Feb;68(1):29-36. Czech.

PMID:
22679695
[PubMed - indexed for MEDLINE]
5.

Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.

Honda S, Hirabayashi H, Tsukahara Y, Negi A.

Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):1061-3. doi: 10.1007/s00417-008-0786-7. Epub 2008 Mar 5.

PMID:
18320201
[PubMed - indexed for MEDLINE]
6.

Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.

Lee JY, Chae JB, Yang SJ, Yoon YH, Kim JG.

Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1257-62. doi: 10.1007/s00417-010-1375-0.

PMID:
20393741
[PubMed - indexed for MEDLINE]
7.

Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

Chung EJ, Kim JH, Ahn HS, Koh HJ.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1727-30. Epub 2007 Aug 10.

PMID:
17690897
[PubMed - indexed for MEDLINE]
8.

Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity.

Atchaneeyasakul LO, Trinavarat A.

J Perinatol. 2010 Jul;30(7):497-9. doi: 10.1038/jp.2009.166.

PMID:
20585321
[PubMed - indexed for MEDLINE]
9.

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Nazari H, Modarres M, Parvaresh MM, Ghasemi Falavarjani K.

Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1713-8. doi: 10.1007/s00417-010-1430-x. Epub 2010 Jun 27.

PMID:
20582706
[PubMed - indexed for MEDLINE]
10.

Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.

Dani C, Frosini S, Fortunato P, Bertini G, Pratesi S, Pollazzi L, Caputo R, La Torre A.

J Matern Fetal Neonatal Med. 2012 Nov;25(11):2194-7. doi: 10.3109/14767058.2012.684109. Epub 2012 May 14.

PMID:
22506618
[PubMed - indexed for MEDLINE]
11.

Intravitreal injection of bevacizumab for retinopathy of prematurity.

Kuniyoshi K, Sugioka K, Sakuramoto H, Kusaka S, Wada N, Shimomura Y.

Jpn J Ophthalmol. 2014 May;58(3):237-43. doi: 10.1007/s10384-014-0310-z. Epub 2014 Feb 26.

PMID:
24566819
[PubMed - indexed for MEDLINE]
12.

Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Roohipoor R, Ghasemi H, Ghassemi F, Karkhaneh R, Riazi-Esfahani M, Nili-Ahmadabadi M.

Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1295-301. doi: 10.1007/s00417-011-1678-9. Epub 2011 Apr 15.

PMID:
21494873
[PubMed - indexed for MEDLINE]
13.

An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan.

Wu WC, Kuo HK, Yeh PT, Yang CM, Lai CC, Chen SN.

Am J Ophthalmol. 2013 Jan;155(1):150-158.e1. doi: 10.1016/j.ajo.2012.06.010. Epub 2012 Sep 8.

PMID:
22967867
[PubMed - indexed for MEDLINE]
14.

Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).

Wutthiworawong B, Thitiratsanont U, Saovaprut C, Subhangkasen I, Geyuraphun B, Ampornprut A, Phumongkutchai J, Tephusdinnaayuthaya S.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S15-21.

PMID:
22043749
[PubMed - indexed for MEDLINE]
15.

Intravitreal bevacizumab monotherapy for retinopathy of prematurity.

Şahin A, Şahin M, Cingü AK, Çınar Y, Türkcü FM, Yüksel H, Kaya S, Arı Ş, Caça İ.

Pediatr Int. 2013 Oct;55(5):599-603. doi: 10.1111/ped.12124. Epub 2013 Jul 30.

PMID:
23659781
[PubMed - indexed for MEDLINE]
16.

Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.

Kim J, Kim SJ, Chang YS, Park WS.

Retina. 2014 Jan;34(1):77-82. doi: 10.1097/IAE.0b013e318296e26d.

PMID:
23807184
[PubMed - indexed for MEDLINE]
17.

Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.

Wu WC, Yeh PT, Chen SN, Yang CM, Lai CC, Kuo HK.

Ophthalmology. 2011 Jan;118(1):176-83. doi: 10.1016/j.ophtha.2010.04.018. Epub 2010 Jul 29.

PMID:
20673589
[PubMed - indexed for MEDLINE]
18.

Reactivation of retinopathy of prematurity after bevacizumab injection.

Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R.

Arch Ophthalmol. 2012 Aug;130(8):1000-6. Erratum in: Arch Ophthalmol. 2013 Feb;131(2):212.

PMID:
22491394
[PubMed - indexed for MEDLINE]
19.

Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.

Autrata R, Krejcírová I, Senková K, Holoušová M, Doležel Z, Borek I.

Eur J Ophthalmol. 2012 Sep-Oct;22(5):687-94. doi: 10.5301/ejo.5000166.

PMID:
22669848
[PubMed - indexed for MEDLINE]
Free Article
20.

Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.

Sun HJ, Choi KS, Lee SJ.

Jpn J Ophthalmol. 2012 Sep;56(5):476-80. doi: 10.1007/s10384-012-0141-8. Epub 2012 Jul 28.

PMID:
22843138
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk